mySmartBlood

Decode your blood test results using artificial intelligence.

The mySmartBlood application is an in vitro diagnostic medical device, intended to provide you (symptomatic end-user) the information concerning medical conditions or groups of diseases and the respective physiological or pathological states thereof, using your results of in vitro blood examination. It operates by using the machine learning model trained on clinical cases.

You must follow three main steps to obtain results:

1. Measure all the blood parameters from our Mandatory Blood parameter List at your nearest laboratory.

2. Enter and submit the blood test results in the app.

3. Receive your mySmartBlood report including the list of most likely groups of diseases and explanations of blood parameters contributing to the results.

Benefit & Risks:

mySmartBlood is a priceless tool to guide you to the right healthcare professional and can significantly shorten your path to the final diagnosis, which is often associated with expensive diagnostic procedures. That way, the mySmartBlood enables your healthcare professional to make faster and more accurate diagnostic decisions and consequently improves your treatment and reduces your costs of the treatment.

By its inherent design, mySmartBlood does not provide information that could itself be used to confirm or discard health condition, since it always provides a list of max. 5 likely groups of diseases. By providing information in such a format, it enables the healthcare professional to naturally consider multiple options. The interpretation provided by mySmartBlood is only an information to guide you to consult the appropriate healthcare professional.

mySmartBlood is intended to be used for interpreting blood results of Caucasian adult users (older than 18 years old), both female (non-pregnant) and male, with acute and/or chronic conditions in the following fields of internal medicine (Toxicology, Endocrinology, Gastroenterology, Cardiology, Hematology, Nephrology, Pulmonology, Rheumatology).

mySmartBlood is contraindicated for use in:

• users below the age of 18,

• emergency situations in general, e.g.:

•.signs of a heart attack (severe/heavy/crushing chest pain…),

• signs of a stroke (facial weakness, slurred speech, inability to hold both arms up…),

• severe breathing problems,

• any other untoward sign or symptom that may be of urgent nature or necessitate urgent or emergency care,

• pregnancy.

Additional Information and Warnings:

• mySmartBlood is not a diagnostic medical device and you are not allowed and you should not make any decisions based only on the results obtained by mySmartBlood, without consulting a healthcare professional.

• Your diagnosis shall always be determined by the responsible physician based on all available physical findings, patients’ anamneses, symptoms and results of other diagnostic tests.

• Certain kinds of medication therapy can affect mySmartBlood outputs. When consulting with a healthcare professional, please inform them regarding this.

• mySmartBlood can only be used if all parameters from the Mandatory Blood Parameter List are available and the input of the blood parameters and values are correct.

• mySmartBlood can only predict the groups of diseases that are available in its database. All the available groups of diseases are listed in the Instructions For Use, Annex II.

• You should use mySmartBlood if you are showing any kind of medical symptoms. mySmartBlood is not designed for screening purposes.

• Please note that obtainment of the mandatory blood parameter list measurement might be subject to additional costs by your healthcare provider or local laboratory.

• mySmartBlood report is subject to payment of a one-time fee to the amount of CHF 29 per individual report. Please note that exact prices can vary depending on your location, currency and exchange rates.